Corneal ulcer results from excessive collagen degradation in the corneal stroma. Interleukin (IL)-1 promotes this process by activating signaling molecules that include nuclear factor (NF)-B and stimulating the synthesis of matrix metalloproteinases (MMPs) in corneal fibroblasts. NF-B activation is mediated by phosphorylation of the inhibitor IB by IB kinase (IKK)-2 and consequent IB degradation. The authors investigated the effects of the IKK-2 inhibitor [5-(p-fluorophenyl)-2-ureido]thiophene-3-carboxamide (TPCA-1) on collagen degradation by corneal fibroblasts. METHODS. Rabbit corneal fibroblasts were cultured in threedimensional collagen gels. Collagen degradation was evaluated by spectrophotometric quantitation of hydroxyproline in culture supernatants subjected to acid-heat hydrolysis. Expression of MMPs was evaluated by immunoblot analysis, gelatin zymography, and real-time reverse transcription polymerase chain reaction analysis. The phosphorylation and degradation of IB␣ and the subcellular localization of NF-B were examined by immunoblot and immunofluorescence analyses, respectively. RESULTS. IL-1␤-induced collagen degradation by corneal fibroblasts was inhibited by TPCA-1 in a concentration-and timedependent manner. TPCA-1 inhibited the IL-1␤-induced expression of MMP-1, -3, and -9 in these cells at both the mRNA and protein levels and the IL-1␤-induced activation of pro-MMP-2. In contrast to dexamethasone, TPCA-1 inhibited the phosphorylation and degradation of IB␣ and the nuclear translocation of NF-B induced by IL-1␤.
C orneal ulcer is the result of excessive degradation of collagen in the corneal stroma by collagenolytic enzymes derived from infectious microorganisms or by matrix metalloproteinases (MMPs) released from activated keratocytes. Pathologic examination has also revealed the presence of infiltrated neutrophils and other leukocytes in or surrounding corneal ulcers. Enzymes released from neutrophils activate MMPs in various inflammatory conditions. 1 Free lysosomes derived from infiltrated neutrophils have also been detected amid degraded collagen in the corneal stroma, and neutrophils phagocytose such amorphous collagen material in corneal ulcers. 2 The functions of keratocytes, including cell proliferation and the synthesis of collagen and MMPs, are continuously modulated by interaction of the cells with extracellular collagen. We have previously shown that three-dimensional culture of corneal fibroblasts in a collagen gel mimics the in vivo situation more closely than does monolayer culture. 3 We have also established an assay system with which to measure the collagenolytic activity of corneal fibroblasts in such three-dimensional cultures. 4, 5 Interleukin (IL)-1 is a major proinflammatory cytokine produced by immune cells and corneal cells. 6 We have shown that IL-1 stimulates collagen degradation by corneal fibroblasts 7 and is responsible for the stimulatory effect of neutrophils on this process. 8 In addition, the inhibition of IL-1 activity by administration 9 or overexpression 10 of IL-1 receptor antagonist reduces the severity of keratitis in animal models, indicating the importance of this cytokine in corneal ulceration. Indeed, the concentration of IL-1 in tear fluid is increased in persons with corneal ulcer. 11 We have also shown that Pseudomonas aeruginosa elastase, 12 in addition to neutrophils 8 and IL-1, 7 stimulates collagen degradation by corneal fibroblasts, whereas dexamethasone 13 and triptolide 14 inhibit such IL-1-induced collagen degradation.
Transcription factors play an important role in cytokine signal transduction, with nuclear factor (NF)-B a major mediator of signaling by IL-1. 7, 15, 16 In the inactive state, most NF-B complexes consist of the subunits p50 and p65 and are restricted to the cytoplasm as a result of their interaction with the inhibitory protein IB. 17 Cell stimulation with IL-1 triggers the activation of NF-B by inducing the phosphorylation and ubiquitination of IB and its consequent degradation by the proteasome; the released NF-B is then able to translocate to the nucleus and to regulate the expression of its target genes. 18 IB is phosphorylated by the IB kinase (IKK) complex, which consists of the catalytic subunits IKK-1 (also known as IKK-␣) and IKK-2 (also known as IKK-␤) and the regulatory subunit IKK-␥. 19 -21 The specific activity of IKK-2 with regard to phosphorylation of IB is 20 times that of IKK-1, 22 suggesting that IKK-2 plays the dominant role in the activation of NF-B in vivo. 23, 24 A small molecule inhibitor of IKK-2 has recently been investigated for its therapeutic potential in the treatment of inflammatory diseases such as asthma 25 and arthritis. 26 To provide insight into the mechanism of corneal ulceration and to explore new treatment options, we investigated the role of IKK-2 in IL-1-induced collagen degradation by corneal fibroblasts. In particular, we examined the effects of a selective IKK-2 inhibitor on such collagen degradation and on NF-B activation and the expression of MMPs in these cells. The effects of the IKK-2 inhibitor were compared with those of dexamethasone, which is currently used to treat corneal ulcer.
Cell Isolation
Male Japanese albino rabbits (weight range, 2.0 -2.5 kg) were obtained from Biotec (Saga, Japan). This study adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and was approved by the Animal Experimental Committee of Yamaguchi University School of Medicine. Rabbit corneal fibroblasts were isolated and maintained as described previously. 12 In brief, the endothelial layer of the cornea was removed mechanically, and the remaining tissue was incubated with dispase (2 mg/mL, in MEM) for 1 hour at 37°C. After mechanical removal of the epithelial sheet, the remaining tissue was treated with collagenase (2 mg/mL, in MEM) at 37°C until a single-cell suspension of corneal fibroblasts was obtained. Isolated corneal fibroblasts were maintained under a humidified atmosphere containing 5% CO 2 at 37°C in MEM supplemented with 10% fetal bovine serum. Cells were used for experiments after four to eight passages and were harvested at subconfluence in the actively proliferating state.
Three-Dimensional Culture of Corneal Fibroblasts in a Type 1 Collagen Gel
Collagen gels were prepared as described. 12 In brief, corneal fibroblasts were harvested by exposure to trypsin-EDTA, collected by centrifugation, and resuspended in serum-free MEM. Acid-solubilized type 1 collagen (3 mg/mL), 5ϫ DMEM, reconstitution buffer (0.05 M NaOH, 0.26 M Na 2 CO 3 , 0.2 M HEPES [pH 7.3]), and corneal fibroblast suspension (2.2 ϫ 10 6 cells/mL in MEM) were mixed on ice in a ratio of 7:2:1:1. Portions (0.5 mL) of the resultant mixture were added to the wells of a 24-well culture plate and were allowed to solidify in an incubator under 5% CO 2 at 37°C, after which 0.5 mL serum-free MEM containing test agents and plasminogen (360 g/mL) was overlaid and the cultures were returned to the incubator for the indicated times.
The IKK-2 inhibitor was dissolved and diluted in dimethyl sulfoxide; the final concentration of solvent was 0.1% in all cultures containing TPCA-1, and the same amount of vehicle was added to control cultures. At the concentrations used in this study, the IKK-2 inhibitor did not have a cytotoxic effect on corneal fibroblasts (data not shown).
Assay of Collagenolytic Activity
Measurement of degraded collagen in culture supernatants was performed as described previously. 8, 12 In brief, the supernatants from collagen gel incubations were collected, and native collagen fibrils with molecular sizes greater than 100 kDa were removed by ultrafiltration. The filtrate was subjected to hydrolysis with 6 M HCl for 24 hours at 110°C. The amount of hydroxyproline in the hydrolysate was then measured spectrophotometrically, and the amount of degraded collagen was expressed as micrograms of hydroxyproline per well.
Immunoblot Analysis
Immunoblot analysis of MMP-1 and -3 was performed as described previously. 12 In brief, culture supernatants were subjected to SDSpolyacrylamide gel electrophoresis on a 10% gel under reducing conditions, and the separated proteins were transferred electrophoretically to a nitrocellulose membrane. Nonspecific sites of the membrane were blocked, and it was then incubated with antibodies to MMP-1 or to MMP-3. Immune complexes were detected with the use of ECL reagents. Immunoblot analysis of total and phosphorylated forms of IB␣, c-Jun, and MAPKs in cell lysates was also performed as described previously.
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Gelatin Zymography
Gelatin zymography of culture supernatants was performed as described previously. 12 In brief, culture supernatants (4 L) were mixed with 2 L nonreducing SDS sample buffer (125 mM Tris-HCl [pH 6.8], 20% glycerol, 2% SDS, 0.002% bromophenol blue) and then fractionated by SDS-PAGE at 4°C on a 10% gel containing 0.1% gelatin. The gel was then washed in 2.5% Triton X-100 for 1 hour (to promote recovery of protease activity) before incubation for 18 hours at 37°C in a reaction buffer containing 50 mM Tris-HCl (pH 7.5), 5 mM CaCl 2 , and 1% Triton X-100. Finally, the gel was stained with Coomassie brilliant blue.
RT and Quantitative PCR Analysis
Total RNA was isolated from cells and subjected to RT with the use of kits. The abundance of MMP-1, -2, -3, -9, procollagen type 1, fibronectin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs was quantified by real-time PCR analysis with an automated PCR system (LightCycler; Roche Molecular Biochemicals, Indianapolis, IN), as described previously. 8 Sequences of the PCR primers for rabbit MMP-1, -2, -3, -9, and GAPDH cDNAs were also as described previously.
14 Those for rabbit procollagen ␣1 (I) cDNA were 5Ј-CCA-CACAGCCCAGCATTG-3Ј (forward) and 5Ј-TCGCTGCCGTACTCGA-ACT-3Ј (reverse), and those for rabbit fibronectin cDNA were 5Ј-AGCCCTTACAGTTCCGAGT-3Ј (forward) and 5Ј-GTAGGGATCGA-AGCATGAG-3Ј (reverse). These primers yielded PCR products of the expected sizes of 649, 313, 306, 271, 293, 118, and 200 bp, respectively.
Immunofluorescence Staining of NF-B
Immunostaining for NF-B in corneal fibroblasts was performed as described previously. 7 In brief, cells cultured in four-well chamber slides were fixed and permeabilized, and nonspecific sites were blocked. The cells were then incubated overnight at 4°C with antibodies to the p65 subunit of NF-B (1:100 dilution in PBS containing 1% bovine serum albumin), washed, and incubated for 1 hour at room temperature with Alexa Fluor 488 -conjugated secondary antibodies (1:500 dilution in the same solution). They were finally washed, mounted in mounting medium, and examined under a fluorescence microscope (Axiovert; Carl Zeiss Meditec, München-Hallbergmoos, Germany).
Statistical Analysis
Data are presented as mean Ϯ SEM and were analyzed with Dunnett or Scheffé test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Inhibitory Effect of an IKK-2 Inhibitor on Collagen Degradation by Rabbit Corneal Fibroblasts
We first examined the effect of the IKK-2 inhibitor TPCA-1 on collagen degradation by corneal fibroblasts. The cells were cultured in three-dimensional collagen gels for 48 hours in the absence or presence of IL-1␤ (1.0 ng/mL) and in the presence of various concentrations of TPCA-1. In the absence of IL-1␤, TPCA-1 had no significant effect on collagen degradation by corneal fibroblasts at any concentration examined (Fig. 1) . In contrast, TPCA-1 inhibited IL-1␤-induced collagen degradation in a concentration-dependent manner; this effect was significant at concentrations Ն0.1 M and was maximal at 1.0 M.
We also examined the time course of collagen degradation by corneal fibroblasts in the absence or presence of IL-1␤ (1.0 ng/mL) or TPCA-1 (1.0 M). In the absence of IL-1␤, the amount of degraded collagen increased to reach a plateau at 24 hours (Fig. 2 ) and was not affected by the presence of TPCA-1 for up to 48 hours (data not shown). IL-1␤ increased the amount of degraded collagen in a time-dependent manner for at least 48 hours, and this effect was blocked by TPCA-1 at all time points examined (Fig. 2) . Together, these results thus demonstrated that the IKK-2 inhibitor inhibits IL-1␤-induced collagen degradation by corneal fibroblasts.
Inhibitory Effects of an IKK-2 Inhibitor on MMP Expression in Corneal Fibroblasts
To investigate the mechanism by which the IKK-2 inhibitor inhibited IL-1␤-induced collagen degradation by corneal fibroblasts, we next examined its effects on the expression of MMPs by these cells. Corneal fibroblasts were cultured in collagen gels for 48 hours in the absence or presence of IL-1␤ (1.0 ng/mL) and in the presence of various concentrations of TPCA-1. Immunoblot analysis with antibodies to MMP-1 did not detect pro-MMP-1 or active MMP-1 in the culture supernatants of cells incubated in the absence of IL-1␤ (Fig. 3A) . In contrast, a 57-kDa immunoreactive protein corresponding to pro-MMP-1 and 49-and 45-kDa immunoreactive proteins corresponding to active MMP-1 were detected in the culture supernatants of cells incubated with IL-1␤. TPCA-1 inhibited the IL-1␤-induced increases in pro-MMP-1 and active MMP-1 in a concentrationdependent manner.
Immunoblot analysis with antibodies to MMP-3 did not detect pro-MMP-3 or active MMP-3 in culture supernatants of cells incubated in the absence of IL-1␤ (Fig. 3A) . In contrast, 57-and 45-kDa immunoreactive proteins corresponding to pro-MMP-3 and active MMP-3, respectively, were apparent in the culture supernatants of cells incubated with IL-1␤. Again, TPCA-1 inhibited the IL-1␤-induced increases in the pro-MMP-3 and active MMP-3 in a concentration-dependent manner.
We then examined the abundance of MMP-1 and MMP-3 mRNAs in corneal fibroblasts. Cells were cultured in monolayers for 12 hours in the absence or presence of IL-1␤ (1.0 ng/mL) or TPCA-1 (1.0 M), after which the amounts of these mRNAs were determined by RT and real-time PCR analysis. IL-1␤ induced a 43-fold increase in the amount of MMP-1 mRNA, and this effect was inhibited by 87% in the presence of TPCA-1 (Fig. 3B) . Similarly, IL-1␤ induced a 22-fold increase in the amount of MMP-3 mRNA in corneal fibroblasts, and TPCA-1 inhibited this effect of IL-1␤ by 75% (Fig. 3B) .
We examined the effects of IL-1␤ and the IKK-2 inhibitor on the expression of MMP-2 and -9 by gelatin zymography. Analysis of culture supernatants of corneal fibroblasts incubated without IL-1␤ for 48 hours revealed two major bands of 65 and 57 kDa corresponding to pro-MMP-2 and active MMP-2, respec- tively (Fig. 4A ). These bands were not affected by incubation of the cells with TPCA-1 alone. Cell culture in the presence of IL-1␤ (1.0 ng/mL) resulted in an increase in the intensity of the band corresponding to active MMP-2 and the appearance of bands at 92 and 77 kDa corresponding to pro-MMP-9 and active MMP-9, respectively. TPCA-1 inhibited the IL-1␤-induced increases in the amounts of the pro-MMP-9 and active MMP-9 and active MMP2 in a concentration-dependent manner.
RT and real-time PCR analysis revealed that culture of corneal fibroblasts with IL-1␤ (1.0 ng/mL) for 12 hours induced a 24-fold increase in the abundance of MMP-9 mRNA and that TPCA-1 inhibited this effect by 51% (Fig. 4B) . Neither IL-1␤ nor TPCA-1 had a significant effect on the abundance of MMP-2 mRNA (Fig. 4B) .
Consistent with our previous observations, 13 these results showed that IL-1␤ stimulates the synthesis of MMP-1, -3, and -9 in corneal fibroblasts and stimulates the conversion of pro-MMP-2 to active MMP-2. They further show that these effects of IL-1␤ are inhibited by the IKK-2 inhibitor.
We also investigated the effects of the IKK-2 inhibitor on the expression of extracellular matrix genes in corneal fibroblasts. RT and real-time PCR analysis revealed that the abundance of procollagen type 1 mRNA was 1.0 Ϯ 0.1, 0.8 Ϯ 0.2, 1.4 Ϯ 0.2, and 0.8 Ϯ 0.1 arbitrary units (mean Ϯ SEM of values from three experiments) after culture of cells for 12 hours either alone or in the presence of IL-1␤ (1.0 ng/mL), TPCA-1 (1.0 M), or both IL-1␤ and TPCA-1. Corresponding values for fibronectin mRNA were 1.0 Ϯ 0.1, 0.8 Ϯ 0.4, 1.1 Ϯ 0.2, and 0.9 Ϯ 0.1 arbitrary units, respectively. These results thus showed that neither IL-1␤ nor TPCA-1 had a significant effect on the expression of these extracellular matrix genes in corneal fibroblasts.
Comparison of the Effects of an IKK-2 Inhibitor and Dexamethasone on IL-1␤-Induced Collagen Degradation by Corneal Fibroblasts
We next compared the effect of the IKK-2 inhibitor on IL-1␤-induced collagen degradation with that of dexamethasone, which we previously showed inhibited this effect of IL-1␤. 13 Neither TPCA-1 (1.0 M) nor dexamethasone (0.1 nM) affected collagen degradation in the absence of IL-1␤ (Fig. 5 ). In contrast, TPCA-1 and dexamethasone each completely inhibited the stimulatory effect of IL-1␤ on collagen degradation by corneal fibroblasts.
Inhibitory Effects of an IKK-2 Inhibitor on the Phosphorylation of IB␣ and Nuclear Translocation of NF-B
To investigate the mechanism by which the IKK-2 inhibitor blocks IL-1␤-induced MMP expression in corneal fibroblasts, we examined its effects on the NF-B signaling pathway in comparison with those of dexamethasone. We first examined the phosphorylation and degradation of IB␣ in corneal fibroblasts by immunoblot analysis. Cells were cultured for 24 hours in serum-free medium, incubated in the absence or presence of TPCA-1 (1.0 M) or dexamethasone (0.1 nM) for 6 hours, and incubated in the absence or presence of IL-1␤ (1.0 ng/mL) for 30 minutes. Consistent with our previous observations, 7 immunoblot analysis with antibodies to total or phosphorylated forms of IB␣ revealed that IL-1␤ induced the phosphorylation and degradation of this NF-B inhibitor (Fig. 6 ). These effects of IL-1␤ were blocked by TPCA-1 but not by dexamethasone. Neither TPCA-1 nor dexamethasone affected the abundance or phosphorylation of IB␣ in the absence of IL-1␤.
Immunofluorescence analysis revealed that the p65 subunit of NF-B was localized predominantly to the cytoplasm of corneal fibroblasts and that IL-1␤ induced the translocation of this protein to the nucleus (Fig. 7) , as shown previously. 7 Neither TPCA-1 nor dexamethasone affected the subcellular distribution of p65 in the absence of IL-1␤. However, the IKK-2 inhibitor, but not dexamethasone, inhibited the nuclear translocation of p65 induced by IL-1␤.
To investigate further the differences in the mechanism of action of TPCA-1 and dexamethasone, we examined the effects of these agents on signaling by MAPKs and activator protein (AP)-1. Immunoblot analysis with antibodies to total or phosphorylated forms of the AP-1 component c-Jun revealed that IL-1␤ induced the phosphorylation of c-Jun and that this effect was blocked by dexamethasone but not by TPCA-1 (Fig. 8) . Neither TPCA-1 nor dexamethasone affected the abundance or phosphorylation of c-Jun in the absence of IL-1␤. Similar analysis revealed that IL-1␤ induced the phosphorylation of the MAPKs ERK, p38 MAPK, and JNK (Fig. 8) . Dexamethasone inhibited the IL-1␤-induced phosphorylation of JNK, but not that of ERK or p38 MAPK, whereas TPCA-1 had no effect on the IL-1␤-induced phosphorylation of any of these MAPKs.
DISCUSSION
We have shown here that an IKK-2 inhibitor blocked IL-1-induced collagen degradation by corneal fibroblasts and have shown the IL-1-induced expression of MMPs at the mRNA and protein levels in these cells. We previously showed that dexamethasone inhibits these effects of IL-1 in corneal fibroblasts. 13 In addition, our present results show that the IKK-2 inhibitor blocked the IL-1␤-induced activation of NF-B in corneal fibroblasts by inhibiting the phosphorylation and degradation of IB␣, whereas dexamethasone had no such effects. The mechanisms by which the IKK-2 inhibitor and dexamethasone inhibit collagen degradation by corneal fibroblasts thus appear to differ. Our observations suggest that IKK-2 inhibitors are a potential alternative to dexamethasone for the treatment of corneal ulcer.
The proinflammatory cytokine IL-1 plays an important role in corneal ulceration, which is characterized by excessive degradation of collagen in the corneal stroma. IL-1 stimulates collagen degradation not only by corneal fibroblasts 7,13 but by fibroblasts from other tissues, including lung, bronchus, 28 and skin. 29 Corneal fibroblasts express receptors for IL-1. 30 The binding of IL-1 to its receptors induces the activation of NF-B and of MAPKs including ERK, p38 MAPK, and JNK. 31 We previously showed that the activation of NF-B by IL-1 is important for IL-1-induced collagen degradation by corneal fibroblasts. 7 We have also shown previously, and have confirmed in the present study, that IL-1 upregulates the expression of MMP-1, -3, and -9, but not that of MMP-2, in corneal fibroblasts. 13 Similar results have been obtained with lung fibroblasts 28 and vascular smooth muscle cells. 32 In addition, we have shown here that IL-1 induced the conversion of pro-MMP-2 to active MMP-2 in corneal fibroblasts, as it does in cardiac fibroblasts. 33 Activation of NF-B is mediated by the IKK-2-dependent phosphorylation and consequent degradation of IB. 22 We have now shown that the IKK-2 inhibitor TPCA-1 inhibited the IL-1-induced upregulation of MMP-1, -3, and -9 expression in corneal fibroblasts at the mRNA and protein levels and the IL-1-induced activation of pro-MMP-2. It also blocked the IL-1-induced phosphorylation and degradation of IB␣ and the translocation of NF-B from the cytoplasm to the nucleus. These effects of TPCA-1 likely underlie its inhibition of collagen degradation by corneal fibroblasts. In contrast, neither IL-1 nor TPCA-1 affected the expression of genes for the extracellular matrix proteins procollagen type 1 and fibronectin in these cells. We previously showed that dexamethasone inhibits IL-1-induced MMP synthesis in corneal fibroblasts and thereby inhibits IL-1-induced collagen degradation by these cells. 13 We now show that dexamethasone did not inhibit the phosphorylation and degradation of IB␣ or the nuclear translocation of NF-B induced by IL-1 in corneal fibroblasts. Dexamethasone appears to exert its biological effects by various mechanisms, 34 with diverse mechanisms thought to contribute to glucocorticoid-mediated inhibition of the NF-B signaling pathway. 35 Dexamethasone thus inhibits NF-B-dependent transcriptional activity without affecting IB levels or the nuclear translocation of NF-B in primary endothelial cells. 35 Our present results suggest that a similar mechanism may be operative in corneal fibroblasts.
The IKK-2 inhibitor was as effective as dexamethasone in inhibiting IL-1-induced collagen degradation by corneal fibroblasts, but these two agents appear to achieve their effects by distinct mechanisms. In addition to NF-B, the transcription factor AP-1 also contributes to IL-1 signaling and MMP expression.
36 -38 AP-1 is composed of c-Jun and c-Fos proteins and is a major target of mitogen-activated signaling pathways. 39 We found that dexamethasone, but not TPCA-1, inhibited the IL-1-induced phosphorylation of JNK-the principal mediator of AP-1 activation-and that of c-Jun in corneal fibroblasts. Dexamethasone was previously shown to antagonize AP-1 function by inhibiting the phosphorylation of JNK in various cell types. 40, 41 Binding sites for AP-1 are present in the promoters of several MMP genes, including those for MMP-1, -3, and -9, 42 and dexamethasone has been shown to suppress MMP expression by inhibiting AP-1 signaling. 38 The inhibitory effect of dexamethasone on activation of the JNK-AP-1 signaling pathway may therefore also contribute to its inhibition of IL-1-induced collagen degradation by corneal fibroblasts. IKK-2 plays a central role in the activation of NF-B in vivo. 23, 24 Small molecule inhibitors of IKK-2 were recently found to show promise for the treatment of inflammatory diseases such as 
